New Research Study for Psoriatic Arthritis

The IZAR Study for Psoriatic Arthritis

Psoriatic arthritis (PsA) is a painful condition that can affect both the joints and skin. PsA is not caused by overuse of joints or aging – rather, it is the result of an overactive immune system and can affect people at any age.

Common symptoms of psoriatic arthritis include pain or swelling in one or more joints, swollen fingers and/or toes, and patches of red, scaly skin (psoriasis).

If you struggle with psoriatic arthritis, you may qualify for the IZAR Clinical Study, now being offered at select medical centers. The IZAR Study is evaluating an injectable investigational medication aimed at alleviating PsA symptoms. If you qualify and choose to join the IZAR Study, you will receive study-related care and monitoring of your PsA condition at no cost. You may also be compensated for your time and travel to attend any required study visits at your local study doctor’s office.

Get Notified About Upcoming Trials

Sign up to receive information about clinical trials, studies, and surveys in your area – right to your inbox.

Sign up

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.